News & Events

Grants last few years

NIH/NIDDK Phase II SBIR awarded Sept 2015

Human induced pluripotent stem cell-derived beta-cells for drug and toxicity testing.

NIH/NIDDK Phase 1 SBIR awarded July 2016

Diabetes drug screening platforms using patient pancreatic islet-like cells generated from induced pluripotent stem cells.

NIH/NIDDK Phase I SBIR awarded Sept 2016

Development of a rapid and inexpensive luciferase-based high throughput screening assay to identify compounds that alter pancreatic β cell function.

NIH/NIDDK Phase I SBIR awarded Sept 2016

Engineered pancreatic endocrine cells that report beta cell toxicity for use in high throughput screening applications.

WI SBIR Advance awarded 2017

WI SBIR Advance awarded 2017